D D Stocken

Summary

Affiliation: University of Birmingham
Country: UK

Publications

  1. pmc Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme
    Sue Wilson
    Primary Care Clinical Sciences, The University of Birmingham, Birmingham, UK
    BMC Cancer 9:36. 2009
  2. pmc Modelling prognostic factors in advanced pancreatic cancer
    D D Stocken
    Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
    Br J Cancer 99:883-93. 2008

Collaborators

Detail Information

Publications2

  1. pmc Establishing the added benefit of measuring MMP9 in FOB positive patients as a part of the Wolverhampton colorectal cancer screening programme
    Sue Wilson
    Primary Care Clinical Sciences, The University of Birmingham, Birmingham, UK
    BMC Cancer 9:36. 2009
    ..MMP9 has potential for detecting those at risk of having colorectal cancer. The aim of this study is to assess whether MMP9 estimation enhances the predictive value of a positive FOBt...
  2. pmc Modelling prognostic factors in advanced pancreatic cancer
    D D Stocken
    Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, UK
    Br J Cancer 99:883-93. 2008
    ..The functional form of the relationship between continuous covariates and survival should always be assessed. Our model should aid individual patient risk stratification and the design and analysis of future trials in pancreatic cancer...